Ascorbic acid in Charcot–Marie–Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial

BACKGROUND: Ascorbic acid reduced the severity of neuropathy in transgenic mice overexpressing peripheral myelin protein 22 (PMP22), a model of Charcot–Marie–Tooth disease type 1A (CMT1A) associated with the PMP22 duplication. However, in three 1-year trials, ascorbic acid had no benefit in human be...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Pareyson, Davide, Reilly, Mary M, Schenone, Angelo, Fabrizi, Gian Maria, Cavallaro, Tiziana, Santoro, Lucio, Vita, Giuseppe, Quattrone, Aldo, Padua, Luca, Gemignani, Franco, Visioli, Francesco, Laurà, Matilde, Radice, Davide, Calabrese, Daniela, Hughes, Richard AC, Solari, Alessandra
Formato: Artigo
Idioma:Inglês
Publicado: Lancet Pub. Group 2011
Assuntos:
Fast track — Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3154498/
https://ncbi.nlm.nih.gov/pubmed/21393063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1474-4422(11)70025-4
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares